July 31, 2020

Cannabis Weekly Round-Up: Aphria Takes Hit, New Warehouse for OCS

Aphria CEO Irwin Simon is looking ahead to the future — he said he sees opportunity in the US and...
March 23, 2020

FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario

FSD Pharma Inc. has taken steps to mitigate the impact of the novel coronavirus SARS-CoV-2 pandemic on its wholly-owned subsidiary,...
March 9, 2020

FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)

FSD Pharma Inc. announced receipt of approval from the Ethics Committee of the Alfred Hospital to initiate a Phase 1, placebo-controlled study.
March 4, 2020

FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange On Friday, March 6, 2020

FSD Pharma Inc. (Nasdaq: HUGE, CSE: HUGE, FRA: 0K9A) will be ringing the opening bell at the Canadian Securities Exchange...
February 20, 2020

FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) today announced the sale of its 12% equity interest in Cannara Biotech Inc.
February 5, 2020

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC

FSD Pharma Inc. announces that Raza Bokhari, MD, Executive Co-Chairman and CEO will be participating in the 22nd Annual BIO CEO...
February 4, 2020

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project

FSD Pharma and Solarvest are pleased to announce that the Parties have agreed to amendments to the Collaborative Research and...